Tomasz qualified as a medical doctor in 1998 in Krakow, Poland. Subsequently he gained broad clinical experience and was involved in academic research and regional medical liaison.  Since 2006 Tomasz has been based in the UK, focused on clinical research in diverse indications, notably oncology (including solid tumours as well as haematological malignancies), rare and auto-immune diseases. Tomasz is qualified as a specialist pharmaceutical physician and has in-depth pharmacovigilance experience including acting as EU Deputy QPPV. 

Tomasz was previously Vice President of TMC Pharma Services, a Pharmaceutical Development Organisation, which he joined in 2016. Prior to that he was Medical Director at Simbec-Orion, a clinical development CRO, and previously Medical Monitor at Allergan Inc.